Needham Initiates Coverage On InflaRx with Buy Rating, Announces Price Target of $8
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
Needham analyst Joseph Stringer initiates coverage on InflaRx (NASDAQ:IFRX) with a Buy rating and announces Price Target of $8.
Needham analyst Joseph Stringer initiates coverage on InflaRx (NASDAQ:IFRX) with a Buy rating and announces Price Target of $8.